✦ LIBER ✦

Immunotherapy with autologous antigen presenting cells for the treatment of androgen independent prostate cancer

✍ Scribed by Paul F. Schellhammer; Robert M. Hershberg

Book ID: 106032930
Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 159 KB
Volume: 23
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-004-0475-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of androgen-independent tumo

Development of androgen-independent tumor cells and their implication for the treatment of prostatic cancer

✍ Isaacs, J.T. ;Kyprianou, N. 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 713 KB

Development of androgen-independent prostatic cancer cells from androgen-responsive cells can occur by a variety of mechanisms (e.g., environmental adaptation, multifocal origin, or genetic instability). Regardless of the mechanism of development, however, once androgen-independent cancer cells beco

Treatment of prostate cancer cells with

Treatment of prostate cancer cells with adenoviral vector-mediated antisense RNA using androgen-dependent and androgen-independent promoters

✍ Wei Li 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 774 KB

Combination immunotherapy with prostatic

Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy

✍ Brian I. Rini; Vivian Weinberg; Lawrence Fong; Shauna Conry; Robert M. Hershberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Phase II study of capecitabine combined

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes

✍ Alan Rodney; Pauline Dieringer; Paul Mathew; Eric Jonasch; Nizar Tannir; Lance C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## Abstract ## BACKGROUND The primary objective of the current study was to evaluate the effectiveness of capecitabine and gemcitabine in the treatment of patients with androgen‐independent prostate cancer (AIPCa) who experienced disease progression after taxane therapy. The secondary objective wa

Detection of circulating tumor cells in

Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer

✍ Michael C. Mitas; Uzair B. Chaudhary; David T. Marshall; Sebastiano Gattoni-Cell 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

## Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer To the Editor: The presence of circulating tumor cells (CTC) in the peripheral blood of cancer patients has attracted a great deal of attention among invest

Up-regulation of Bcl-2 is required for t

Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage

✍ Lin, Yuting; Fukuchi, Junichi; Hiipakka, Richard A; Kokontis, John M; Xiang, Jia 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 421 KB